Nasdaq:US$11.88 (+0.00) | HKEX:HK$19.10 (+0.12) | AIM:£1.91 (-0.05)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 16 Apr 2023

AACR 2023: Preclinical characteristic of HMPL-306, a CNS-penetrable dual inhibitor of mutant IDH1 and IDH2